Tempest Therapeutics
Tempest Therapeutics's Overview
Tempest Therapeutics is a clinical-stage oncology company focused on developing novel small molecule therapeutics that combine rationally and mechanistically to harness the power of the immune system to fight cancer. Their approach involves targeting critical immune-regulatory pathways to create potent and differentiated cancer treatments. Tempest is dedicated to advancing its pipeline of drug candidates through rigorous clinical trials to address unmet medical needs in oncology.
Where is Tempest Therapeutics's Headquarters?
HQ Function
Serves as the company's main administrative, research, and development center, overseeing clinical trial strategies, drug discovery, and corporate operations.
Notable Features:
Modern laboratory and office facilities located within a major U.S. biotechnology hub, providing access to advanced infrastructure and a rich talent pool.
Work Culture:
Emphasizes scientific rigor, innovation, and collaboration, with a strong focus on developing breakthrough cancer treatments. The culture is likely fast-paced and mission-driven, typical of clinical-stage biotech companies.
HQ Significance:
Its location in South San Francisco places Tempest Therapeutics at the heart of the biotech industry, facilitating partnerships, talent acquisition, and access to cutting-edge research and development resources.
Values Reflected in HQ: The choice of location and facility underscores a commitment to innovation, scientific excellence, and strategic positioning within the biopharmaceutical ecosystem to advance cancer therapies.
Location:
Tempest Therapeutics's global presence is primarily characterized by its international clinical trial sites and collaborations for its oncology drug candidates. Core research, development strategy, and corporate functions are centralized at its headquarters in South San Francisco, California, USA.
Street Address:
7000 Shoreline Court, Suite 275
City:
South San Francisco
State/Province:
CA
Country:
USA
Tempest Therapeutics's Global Presence
Buying Intent Signals for Tempest Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Tempest Therapeutics
As of April 2025, Tempest Therapeutics' leadership includes:
Investors of Tempest Therapeutics
Tempest Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Tempest Therapeutics appointed a new Chief Development Officer in the past 12 months, enhancing its leadership team for ongoing and future clinical programs. No other major C-suite executive changes have been publicly announced during this period.
New Appointments:
Technology (Tech Stack) used by Tempest Therapeutics
Discover the tools Tempest Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Tempest Therapeutics Email Formats and Examples
Tempest Therapeutics commonly uses the email format of the employee's first initial followed by their last name. This is a standard convention for many companies in the biotech sector.
[first_initial][last]@tempesttx.com
Format
sbrady@tempesttx.com
Example
85%
Success rate
News and media
GlobeNewswire • May 9, 2024
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
Tempest Therapeutics announced its financial results for the first quarter ended March 31, 2024, and provided updates on its clinical programs, including advancements with TPST-1120 and TPST-1495....more
GlobeNewswire • May 2, 2024
Tempest to Present at the Citizens JMP Life Sciences Conference
Tempest Therapeutics announced that its management team would present at the Citizens JMP Life Sciences Conference in New York, NY, on May 13, 2024....more
GlobeNewswire • April 5, 2024
Tempest Announces Positive Data from the Global Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma (HCC)
Tempest Therapeutics reported encouraging new and updated data from its ongoing Phase 1b/2 clinical trial evaluating TPST-1120 in combination with atezolizumab and bevacizumab in first-line hepatocellular carcinoma....more
GlobeNewswire • March 7, 2024
Tempest Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Tempest Therapeutics provided its financial results for the fourth quarter and full year 2023, alongside a business update on its pipeline progress and upcoming milestones for its oncology programs....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Tempest Therapeutics, are just a search away.